To further confirm that PPP2R3A was a direct target of miR-652 in prostate cancer cells, PC3 cells were transfected with either miR-652 mimic alone, or in combination with anti-miR-652 antagomir, and compared to control cells transfected with a control mimic. Here, PPP2R3A is linked to prostate cancer.